I

INIFY Laboratories AB
OSE:INIFY

Watchlist Manager
INIFY Laboratories AB
OSE:INIFY
Watchlist
Price: 3.6 NOK
Market Cap: 284m NOK

Operating Margin

-9 120.5%
Current
Improving
by 11 544.1%
vs 3-y average of -20 664.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-9 120.5%
=
Operating Income
kr-40.8m
/
Revenue
kr409k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-9 120.5%
=
Operating Income
kr-40.8m
/
Revenue
kr409k

Peer Comparison

Country Company Market Cap Operating
Margin
SE
INIFY Laboratories AB
OSE:INIFY
284m NOK
Loading...
US
CVS Health Corp
NYSE:CVS
101.7B USD
Loading...
US
Cigna Corp
NYSE:CI
72.3B USD
Loading...
US
Cigna Group
XMUN:CGN
62B EUR
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
26.5B EUR
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
21.3B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
22.5B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
21B USD
Loading...
US
Guardant Health Inc
NASDAQ:GH
14.4B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.4B EUR
Loading...
AU
Sonic Healthcare Ltd
ASX:SHL
11.2B AUD
Loading...
No Stocks Found

Market Distribution

Lower than 97% of companies in Sweden
Percentile
3nd
Based on 2 047 companies
3nd percentile
-9 120.5%
Low
-2 025 693.8% — -1.8%
Typical Range
-1.8% — 12.5%
High
12.5% — 10 459.2%
Distribution Statistics
Sweden
Min -2 025 693.8%
30th Percentile -1.8%
Median 6%
70th Percentile 12.5%
Max 10 459.2%

INIFY Laboratories AB
Glance View

Market Cap
284m NOK
Industry
Health Care

INIFY Laboratories AB engages in the provision of cancer diagnostics through laboratory services within pathology. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2022-06-20. The firm uses a fully digital, standardized and Artificial Intelligence (AI)- supported workflow to optimize quality and response times, initially within prostate. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. INIFY Laboratories' laboratory in Solna, Sweden is intended to provide two types of analyses of prostate Biopsy Specimens to clients: Full pathology Report signed by an INIFY subspecialized pathologist and Whole Slide Images (WSI) generation and result of Pathology Decision Support Tool (PDST) analysis only. The firm origins from ContextVision.

INIFY Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-9 120.5%
=
Operating Income
kr-40.8m
/
Revenue
kr409k
What is INIFY Laboratories AB's current Operating Margin?

The current Operating Margin for INIFY Laboratories AB is -9 120.5%, which is above its 3-year median of -20 664.7%.

How has Operating Margin changed over time?

Over the last 5 months, INIFY Laboratories AB’s Operating Margin has increased from -31 097.3% to -9 120.5%. During this period, it reached a low of -31 097.3% on May 30, 2023 and a high of -10 232% on Oct 30, 2023.

Back to Top